Abstract

Due to the high surface: volume ratio and the extraordinary properties arising from the nanoscale (optical, electric, magnetic, etc.), nanoparticles (NPs) are excellent candidates for multiple applications. In this context, nanoscience is opening a wide range of modern technologies in biological and biomedical fields, among others. However, one of the main drawbacks that still delays its fast evolution and effectiveness is related to the behavior of nanomaterials in the presence of biological fluids. Unfortunately, biological fluids are characterized by high ionic strengths which usually induce NP aggregation. Besides this problem, the high content in biomacromolecules—such as lipids, sugars, nucleic acids and, especially, proteins—also affects NP stability and its viability for some applications due to, for example, the formation of the protein corona around the NPs. Here, we will review the most common strategies to achieve stable NPs dispersions in high ionic strength fluids and, also, antifouling strategies to avoid the protein adsorption.

Highlights

  • The use of inorganic nanoparticles (NPs) for biological and medical applications has attracted great attention in recent decades. This is clearly demonstrated by the large increase in publications reporting the use of nanotechnology for biomedical purposes [1,2,3,4,5,6,7,8,9,10], which can be summarized in three main properties arising from the nanoscale: (i) the similar size to biomacromolecules allows for a better interaction of NPs with cells and biomolecules [11]; (ii) the high NP surface: volume ratio facilitates the incorporation of a high density of functional moieties [12]; and, (iii) the unique physicochemical properties derived from the nanoscale size

  • In contrast with the electrostatic stabilization, where the charge is defined during the synthesis steps stabilization, where the charge is defined during the synthesis steps of the NPs, steric stabilization of the NPs, steric stabilization usually requires an additional step of functionalization of the usually requires an additional step of functionalization of the preformed colloids (Figure 1) [29,30]

  • The stability of these particles was monitored in phosphate buffered saline (PBS) plus 10% fetal bovine serum (FBS) in a normal cell culture condition without observing any detectable agglomeration

Read more

Summary

Introduction

The use of inorganic nanoparticles (NPs) for biological and medical applications has attracted great attention in recent decades. Neutralized with the subsequent aggregation due todue vanto dervan electrostatic electrostatic stabilization largely fails to provide sufficient colloidal stability in biological media. In contrast with the electrostatic stabilization, where the charge is defined during the synthesis steps stabilization, where the charge is defined during the synthesis steps of the NPs, steric stabilization of the NPs, steric stabilization usually requires an additional step of functionalization of the usually requires an additional step of functionalization of the preformed colloids (Figure 1) [29,30]. Thisparticles corona can causethe so-called “protein [31,32,33,34,35] This corona can cause two main issues: particle destabilization two main issues: corona”.

Strategies
Surface
PEG as Stabilizing Agent in Biological Systems
Citrate-Stabilized Particles
CTAB-Stabilized Au NPs
PEG Coating of Magnetic NPs
PEG Coating of Quantum Dots
PEG Interaction with
PEG Drawbacks
Zwitterionic Ligands
Zwitterionic Coating of Plasmonic NPs
Zwitterionic Coating of QDs
Zwitterionic Coating of Magnetic NPs
Drawbacks of Zwitterionic Coatings
Lipid Bilayer
Lipid Bilayer Coating of Plasmonic NPs
Lipid Bilayer Coating of Fluorescent NPs
Lipid The
Drawbacks of Lipidicthe
Protein
Protein Coating of Magnetic NPs
Drawbacks of Protein Coatings
Glycans
Glycans Coating of Noble NPs
Glycans Coating of QDs
Drawbacks of Glycans Coatings
Mercaptoalkyl Acid Ligands
Mercaptoalkyl Acid Ligands on Plasmonic NPs
Mercaptoalkyl Acid Ligands on QDs
Mercaptoalkyl Acid Ligands on Magnetic NPs
Drawbacks of Mercaptoalkyl Acid Ligands
10. Aptamers
10.1. Aptamer Coating of Plasmonic NPs
10.2. Thiol-modified
10.3. Aptamer of Magnetic
11. NPs Immobilization on Colloidal Substrates
12. Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call